SpectrumDNA Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
SpectrumDNA has 59.28 million shares outstanding.
| Current Share Class | 59.28M |
| Shares Outstanding | 59.28M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -591.45 |
Financial Efficiency
Return on equity (ROE) is -1,302.67% and return on invested capital (ROIC) is -739.50%.
| Return on Equity (ROE) | -1,302.67% |
| Return on Assets (ROA) | -391.70% |
| Return on Invested Capital (ROIC) | -739.50% |
| Return on Capital Employed (ROCE) | 1,703.91% |
| Weighted Average Cost of Capital (WACC) | -156.37% |
| Revenue Per Employee | 17,656 |
| Profits Per Employee | -129,384 |
| Employee Count | 8 |
| Asset Turnover | 0.63 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -29.20 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 41.57 |
| Average Volume (20 Days) | 10,306 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SpectrumDNA had revenue of 141,250 and -1.04 million in losses. Loss per share was -0.01.
| Revenue | 141,250 |
| Gross Profit | 137,167 |
| Operating Income | -1.41M |
| Pretax Income | -1.40M |
| Net Income | -1.04M |
| EBITDA | -1.41M |
| EBIT | -1.41M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 4,222 in cash and n/a in debt, with a net cash position of 4,222 or 0.00 per share.
| Cash & Cash Equivalents | 4,222 |
| Total Debt | n/a |
| Net Cash | 4,222 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | -82,647 |
| Book Value Per Share | -0.00 |
| Working Capital | -83,092 |
Cash Flow
In the last 12 months, operating cash flow was -346,619 and capital expenditures -1,199, giving a free cash flow of -347,818.
| Operating Cash Flow | -346,619 |
| Capital Expenditures | -1,199 |
| Free Cash Flow | -347,818 |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | 97.11% |
| Operating Margin | -996.98% |
| Pretax Margin | -993.89% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SpectrumDNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.03% |
| Shareholder Yield | -10.03% |
| Earnings Yield | -1,754,354.24% |
| FCF Yield | -589,522.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SpectrumDNA has an Altman Z-Score of -3879.7 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3879.7 |
| Piotroski F-Score | 3 |